Is There A Better Place To Decide What’s Right For Patients?
Who should decide when evidence for a drug sufficient to support a patient’s decision to give it a try?
The FDA Did The Right Thing By Approving a Novel Drug For A Disabling Disease
The FDA’s decision reflects a thoughtful, not knee-jerk approach to its mission, which is to protect the public from fraudulent and unsafe substances. What’s at issue is how well eteplirsen works. And that it’s too expensive.